{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:04Z","timestamp":1792784944979,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Technology of China","award":["2013ZX09301307"],"award-info":[{"award-number":["2013ZX09301307"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hong Kong General Research Fund","award":["HKBU479111"],"award-info":[{"award-number":["HKBU479111"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU478312"],"award-info":[{"award-number":["HKBU478312"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU262913"],"award-info":[{"award-number":["HKBU262913"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU12102914"],"award-info":[{"award-number":["HKBU12102914"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU261113"],"award-info":[{"award-number":["HKBU261113"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU212111"],"award-info":[{"award-number":["HKBU212111"]}]},{"name":"Hong Kong General Research Fund","award":["HKBU212613"],"award-info":[{"award-number":["HKBU212613"]}]},{"name":"Hong Kong General Research Fund","award":["CUHK14112915"],"award-info":[{"award-number":["CUHK14112915"]}]},{"name":"Hong Kong General Research Fund","award":["CUHK489213"],"award-info":[{"award-number":["CUHK489213"]}]},{"name":"Natural Science Foundation Council of China","award":["81272045"],"award-info":[{"award-number":["81272045"]}]},{"name":"Natural Science Foundation Council of China","award":["81703049"],"award-info":[{"award-number":["81703049"]}]},{"name":"Natural Science Foundation Council of China","award":["81272045"],"award-info":[{"award-number":["81272045"]}]},{"name":"Natural Science Foundation Council of China","award":["81401833"],"award-info":[{"award-number":["81401833"]}]},{"name":"Natural Science Foundation Council of China","award":["81470072"],"award-info":[{"award-number":["81470072"]}]},{"name":"Natural Science Foundation Council of China","award":["N_HKBU435\/12"],"award-info":[{"award-number":["N_HKBU435\/12"]}]},{"DOI":"10.13039\/501100001692","name":"Croucher Foundation","doi-asserted-by":"publisher","award":["Gnt#CAS14BU\/CAS14201"],"award-info":[{"award-number":["Gnt#CAS14BU\/CAS14201"]}],"id":[{"id":"10.13039\/501100001692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-IRMS\/12-13\/02"],"award-info":[{"award-number":["RC-IRMS\/12-13\/02"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-IRMS\/13-14\/02"],"award-info":[{"award-number":["RC-IRMS\/13-14\/02"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-IRMS\/15-16\/01"],"award-info":[{"award-number":["RC-IRMS\/15-16\/01"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hong Kong Baptist University Strategic Development Fund","award":["SDF13-1209-P01"],"award-info":[{"award-number":["SDF13-1209-P01"]}],"id":[{"id":"https:\/\/ror.org\/0145fw131","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hong Kong Research Grants Council Early Career Scheme","award":["489213"],"award-info":[{"award-number":["489213"]}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-ICRS\/14-15\/01"],"award-info":[{"award-number":["RC-ICRS\/14-15\/01"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["FRG1\/13-14\/024"],"award-info":[{"award-number":["FRG1\/13-14\/024"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["FRG2\/13-14\/006"],"award-info":[{"award-number":["FRG2\/13-14\/006"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["FRG2\/14-15\/010"],"award-info":[{"award-number":["FRG2\/14-15\/010"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["FRG2\/14-15\/063"],"award-info":[{"award-number":["FRG2\/14-15\/063"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["Z0252"],"award-info":[{"award-number":["Z0252"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["Z0293"],"award-info":[{"award-number":["Z0293"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Innovation Commission of Shenzhen Municipality Funds","award":["JCYJ20170307161659648"],"award-info":[{"award-number":["JCYJ20170307161659648"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biomaterials.2017.09.015","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T08:45:49Z","timestamp":1505292349000},"page":"68-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"special_numbering":"C","title":["Tumor cell-targeted delivery of CRISPR\/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma"],"prefix":"10.1016","volume":"147","author":[{"given":"Chao","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Kang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atik Badshah","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.W.T.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.09.015_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pharmthera.2012.09.003","article-title":"New targets and approaches in osteosarcoma","volume":"137","author":"Gill","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coph.2014.02.002","article-title":"Recent advances in osteosarcoma","volume":"16","author":"Botter","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/2278-330X.110483","article-title":"Osteosarcoma relapse as pleural metastasis","volume":"2","author":"Saha","year":"2013","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0019-5413.132491","article-title":"Classification, imaging, biopsy and staging of osteosarcoma","volume":"48","author":"Kundu","year":"2014","journal-title":"Indian J. Orthop."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1634\/theoncologist.7-2-144","article-title":"Osteogenic sarcoma presenting with lung metastasis","volume":"7","author":"Staddon","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","article-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","volume":"314","author":"Link","year":"1986","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.25744","article-title":"Addition of pamidronate to chemotherapy for the treatment of osteosarcoma","volume":"117","author":"Meyers","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1005766511385","article-title":"Angiogenic factors as tumor markers","volume":"15","author":"Nguyen","year":"1997","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2174\/138945010791591395","article-title":"Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy","volume":"11","author":"Niu","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib13","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1002\/cncr.26116","article-title":"Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma","volume":"117","author":"Yang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10585-012-9543-8","article-title":"Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy","volume":"30","author":"Tanaka","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121568","article-title":"The growth and aggressive behavior of human osteosarcoma is regulated by a CaMKII-controlled autocrine VEGF signaling mechanism","volume":"10","author":"Daft","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib16","first-page":"12411","article-title":"VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K\/AKT signaling pathway","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib17","first-page":"15","article-title":"Advances in therapeutic CRISPR\/Cas9 genome editing","volume":"168","author":"Savic","year":"2016","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib18","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nbt.3235","article-title":"Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains","volume":"33","author":"Shi","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nbt.3245","article-title":"Photoactivatable CRISPR-Cas9 for optogenetic genome editing","volume":"33","author":"Nihongaki","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/cr.2017.16","article-title":"A\u00a0non-viral CRISPR\/Cas9 delivery system for therapeutic gene targeting in\u00a0vivo","volume":"27","author":"Jiang","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2010.0264","article-title":"Cell-specific aptamer-mediated targeted drug delivery","volume":"21","author":"Zhou","year":"2011","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib24","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.2174\/092986711797189547","article-title":"Tumor-targeted drug delivery with aptamers","volume":"18","author":"Zhang","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2005.09.024","article-title":"Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer","volume":"109","author":"Fewell","year":"2005","journal-title":"J.\u00a0Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/bm025563c","article-title":"Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery","volume":"3","author":"Wang","year":"2002","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1023\/A:1015166806366","article-title":"Novel water insoluble lipoparticulates for gene delivery","volume":"19","author":"Furgeson","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2014.03.571","article-title":"A\u00a0phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study","volume":"133","author":"Alvarez","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib30","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/ATVBAHA.114.304088","article-title":"MicroRNA-24 regulates macrophage behavior and retards atherosclerosis","volume":"34","author":"Di Gregoli","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2013.08.020","article-title":"VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity","volume":"26","author":"Giannotta","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib32","first-page":"82","article-title":"Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens\u2013evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor","volume":"7","author":"Miettinen","year":"1994","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib33","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/nar\/gkp489","article-title":"Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus","volume":"37","author":"Cao","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2543","article-title":"Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX","volume":"218","author":"Li","year":"2009","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib35","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nprot.2010.66","article-title":"Development of DNA aptamers using Cell-SELEX","volume":"5","author":"Sefah","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113232","article-title":"Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53","volume":"9","author":"Lawhorn","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib39","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Patrick","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2005.09.024","article-title":"Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer","volume":"109","author":"Jason","year":"2005","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib42","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1242\/jcs.010686","article-title":"Dynamin 2 mediates fluid-phase micropinocytosis in epithelial cells","volume":"120","author":"Cao","year":"2007","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib43","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.18632\/oncotarget.1503","article-title":"The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer","volume":"4","author":"Li","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1541-7786.MCR-11-0473","article-title":"Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells","volume":"10","author":"Zhang","year":"2012","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.gt.3302221","article-title":"Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins","volume":"11","author":"Basner-Tschakarjan","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib47","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.mvr.2007.05.006","article-title":"In\u00a0vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents","volume":"74","author":"Goodwin","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/bonekey.2015.37","article-title":"Preclinical mouse models of osteosarcoma","volume":"4","author":"Uluckan","year":"2015","journal-title":"BoneKEy Rep."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.2540","article-title":"Key contribution of CPEB4-mediated translational control to cancer progression","volume":"18","author":"Ortiz-Zapater","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jbmr.535","article-title":"Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice","volume":"27","author":"Sabile","year":"2012","journal-title":"J.\u00a0Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib51","first-page":"1110","article-title":"A\u00a0review on angiogenesis and its assays","volume":"15","author":"Tahergorabi","year":"2012","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.blo.0000229333.98781.56","article-title":"VEGF and BMP expression in mouse osteosarcoma cells","volume":"450","author":"Weiss","year":"2006","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/nat.2011.0313","article-title":"Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling","volume":"21","author":"Rockey","year":"2011","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib55","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/CIRCULATIONAHA.107.724864","article-title":"First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers","volume":"116","author":"Gilbert","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib56","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/nnm.11.141","article-title":"Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming","volume":"6","author":"Wang","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib57","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1074\/jbc.M503202200","article-title":"High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression","volume":"281","author":"Khalil","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2015.02.002","article-title":"miR-487b promotes human umbilical vein endothelial cell proliferation, migration, invasion and tube formation through regulating THBS1","volume":"591","author":"Feng","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nprot.2011.435","article-title":"Use of the mouse aortic ring assay to study angiogenesis","volume":"7","author":"Baker","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib60","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/nprot.2015.097","article-title":"The fetal mouse metatarsal bone explant as a model of angiogenesis","volume":"10","author":"Song","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.mt.6300323","article-title":"Tumor-targeted delivery of siRNA by self-assembled nanoparticles","volume":"16","author":"Li","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A\u00a0delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib63","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3892\/ol.2015.3444","article-title":"Identification and functional study of osteosarcoma metastasis marker genes","volume":"10","author":"Shi","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molmed.2004.03.001","article-title":"Ezrin, a key component in tumor metastasis","volume":"10","author":"Hunter","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib66","first-page":"1355","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis","volume":"34","author":"Merdad","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib67","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1158\/1078-0432.CCR-08-0746","article-title":"Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics","volume":"14","author":"Mita","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/exmp.2002.2424","article-title":"Expression of the endothelial markers PECAM-1, vWf, and CD34 in\u00a0vivo and in\u00a0vitro","volume":"72","author":"Muller","year":"2002","journal-title":"Exp. Mol. Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2017.09.015_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.5-suppl_1-3","article-title":"VEGF receptor signaling in tumor angiogenesis","volume":"5","author":"McMahon","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib70","article-title":"Clinical trials referral resource: current clinical trials of the anti-VEGF monoclonal antibody bevacizumab","volume":"15","author":"Chen","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib71","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1158\/1078-0432.CCR-13-2364","article-title":"Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing","volume":"20","author":"Turner","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib72","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acsnano.6b04261","article-title":"Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.09.015_bib74","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/cib.3.6.13495","article-title":"Multifaceted regulation of T cells by CD44","volume":"3","author":"Baaten","year":"2010","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib75","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/hum.2015.069","article-title":"Challenges in CRISPR\/CAS9 delivery: potential roles of nonviral vectors","volume":"26","author":"Li","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nbt.3469","article-title":"A\u00a0dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice","volume":"34","author":"Yang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib77","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.3471","article-title":"Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in\u00a0vivo","volume":"34","author":"Yin","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2017.09.015_bib78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/gt.2009.159","article-title":"Phase-I clinical trial of IL-12 plasmid\/lipopolymer complexes for the treatment of recurrent ovarian cancer","volume":"17","author":"Anwer","year":"2010","journal-title":"Gene Ther."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217305781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217305781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:29:10Z","timestamp":1758904150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217305781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":78,"alternative-id":["S0142961217305781"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.015","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cell-targeted delivery of CRISPR\/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}